U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07561502) titled 'Transurethral Periprostatectomy Treatment of Cancerous Prostate Tissue' on April 17.
Brief Summary: This goal of this clinical trial is to determine if the Vanquish System can safely and effectively treat cancerous tissue in the prostate. Researchers will also determine the best treatment dose, monitor safety during and immediately after the procedure, and examine prostate tissue after surgical removal to confirm how well the treatment destroyed targeted tissue. Patients enrolled have been diagnosed with prostate cancer and will undergo treatment with the Vanquish System before their scheduled radical prostatectomy.
Study Start Date:...